-
The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study
Frazzei, G., Cramer, S. H. M., Landewé, R. B. M., Maijer, K. I., Gerlag, D. M., Tak, P. P., de Vries, N., van Baarsen, L. G. M., van Vollenhoven, R. F. & Tas, S. W., 18 Oct 2024, In: RMD open. 10, 4Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
